JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
2 hedge funds and large institutions have $166K invested in Juno Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 232 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-235
Holders Change %
-99.16%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
232
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$482M |
| 2 |
CM
Crestline Management
Fort Worth,
Texas
|
-$349M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$320M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$287M |
| 5 |
BlackRock
New York
|
-$221M |
